IVF and Gene Editing: Why the Church Draws the Line Where She Does

In vitro fertilization and gene editing are often presented, by critics of Catholic teaching, as cases where the Church’s moral theology simply obstructs medicine from delivering plainly good outcomes — a child for a couple who cannot otherwise conceive, a cure for a devastating inherited disease. Taking the Church’s actual reasoning seriously means granting that these are real goods, and that her objection is not to the goods themselves but to particular means she judges to violate human dignity even in pursuit of a good end — a distinction moral theology draws constantly and that this case is no exception to.

The Church’s teaching on IVF, laid out most fully in the documents Donum Vitae (1987) and Dignitas Personae (2008), does not deny the pain of infertility or dismiss the longing for a child as illegitimate. Her objection rests on the claim, argued at length in Humanae Vitae and developed since, that the unitive and procreative meanings of the conjugal act are inseparable by design, and that new human life should come into being only as the fruit of that act, not as the product of a laboratory procedure that replaces it. IVF as ordinarily practiced also typically involves the creation of multiple embryos, most of whom are discarded, frozen indefinitely, or used in research — and if, as Catholic teaching holds, a new human being with full moral status exists from fertilization, this is not an unfortunate side effect but the destruction of human lives on a routine, industrial scale, which the Church regards as a graver problem than the technique’s disconnection of conception from the marital act, serious as that disconnection is in her view on its own terms. Critics reasonably ask why the marital-act requirement should be treated as absolute rather than one value to be weighed against the good of the child eventually born; the Church’s response is that treating procreation as separable from the act that expresses total spousal self-gift risks treating the child, even unintentionally, as a manufactured product rather than a begotten person — a distinction defenders of the teaching regard as morally serious even when it is not immediately intuitive to those weighing only the outcome.

Gene editing raises a structurally different question, and the Church’s moral theology draws a real distinction within it rather than opposing the technology as a whole. Somatic gene therapy — editing the cells of an already-existing patient to treat or cure a disease, with no effect on that person’s future children — is generally treated as morally permissible in principle, an extension of ordinary medicine’s legitimate work of healing, no different in kind from other therapeutic interventions the Church has always encouraged. Germline editing — altering the genome in a way that is heritable, passed on to all of a person’s descendants — raises graver concerns: it is performed on people who cannot consent (not yet conceived, in fact), it carries risks and unknown long-term consequences imposed on generations who had no say, and its trajectory toward selecting or enhancing traits rather than merely curing disease raises the serious historical shadow of eugenics. Even here, though, the Church’s caution about germline editing tends to be argued on grounds of consent, risk, and the danger of eugenic drift specifically — not on a blanket claim that human beings may never licitly use their God-given intelligence to intervene in nature, since the Church has never held that view; medicine as such, including quite dramatic interventions, has always been regarded as a legitimate participation in human stewardship over creation, including our own.

The consistent thread underneath both cases, and the thing critics who see mere obstruction miss, is that Catholic moral theology is not evaluating outcomes alone — a healthy child, a cured disease — but the means by which those outcomes are reached, on the classical principle that a good end never justifies an intrinsically wrongful means. Whether one accepts that framework’s application to a given case is where the actual disagreement lies; but the disagreement is a real moral argument, weighing real values against each other, not indifference to suffering or hostility to medical progress as such.